跳至主要内容
临床试验/EUCTR2013-004396-12-IT
EUCTR2013-004396-12-IT进行中(未招募)1 期

Efficacy of ketamine in refractory convulsive status epilepticus in children: a multicenter, randomized, controlled, open-label, no-profit, with sequential design study. - KETASER01

Azienda Ospedaliero-Universitaria Meyer0 个研究点目标入组 57 人开始时间: 2014年1月31日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
57

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) Patients 1 month to 18 years old.
  • 2) Diagnosis and clinical EEGrafica of refractory convulsive status epilepticus
  • 3) Refractoriness of the drug I and II line
  • 4) Written informed consent from parents or legal guardian.
  • 5) Administration of rating scales in the risk of mortality (PIM III) and severity of SE (stess, status epilepticusseverity score) to be performed prior to randomization.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 57
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) contraindications to the use of the medication/s in the study.
  • 2) pregnant or suspected pregnant.

研究者

相似试验

Efficacy of ketamine in refractory convulsive status... | 临床试验